Throughout Central Asia, Project HOPE is combating the burdens of tuberculosis, drug-resistant tuberculosis, and TB/HIV co-infection.
What's New in Central Asia
Eliminating TB: A Collaborative Effort
The International Conference of Integrated TB Control in Almaty, Kazakhstan, brought together hundreds of TB experts and health care professionals.
Together Against Tuberculosis
Who said TB awareness campaigns can't be fun? Check out HOPE in Kyrgyzstan.
The Global Fight Against a Potent Killer
A century-and-a-half ago tuberculosis (TB) was such a fact of daily life that the tragic romance of a young woman dying from the disease was immortalized in Giuseppe Verdi’s famous opera La Traviata. No one is writing operas, or their modern equivalent, movies or television shows about TB these days, and most people probably never give it a second thought — even though it is a disease that has afflicted the likes of celebrities like Nelson Mandela, Ringo Star, Sir Tom Jones and Tina Turner.
Global NGO Project HOPE Delivers Crucial Medicines to Uzbekistan
The humanitarian aid, donated by Project HOPE’s partners, is valued at more than USD $2.2 million, and includes antibiotics and antifungal medicines to treat a wide variety of bacterial and fungal infections, as well as medical supplies.
Innovations: Tajikistan GPS Project Demonstrates Initial Success
Late last spring, Project HOPE’s global staff submitted 20 pioneering ideas to be considered for the first Internal Global Health Innovations Challenge. This challenge encouraged staff working at program sites around the world to submit original solutions to improve health for underserved populations.
New Treatment Regimen Brings Hope for MDR-TB Patients
Hundreds of thousands of patients with multidrug resistant tuberculosis (MDR-TB), a form of TB infection caused by bacteria that are resistant to powerful drugs used to cure the disease, suddenly have reason to hope. The World Health Organization (WHO) has just cleared a new shortened treatment regimen for multidrug-resistant tuberculosis (MDR-TB) which carries grave risks for nearly half a million people who developed a condition that killed 190,000 people in 2014.